356 related articles for article (PubMed ID: 7813622)
1. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.
Takumi T; Moustakas A; Lin HY; Lodish HF
Exp Cell Res; 1995 Jan; 216(1):208-14. PubMed ID: 7813622
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas.
Alexander JM; Bikkal HA; Zervas NT; Laws ER; Klibanski A
J Clin Endocrinol Metab; 1996 Feb; 81(2):783-90. PubMed ID: 8636304
[TBL] [Abstract][Full Text] [Related]
3. Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family.
He WW; Gustafson ML; Hirobe S; Donahoe PK
Dev Dyn; 1993 Feb; 196(2):133-42. PubMed ID: 8395914
[TBL] [Abstract][Full Text] [Related]
4. zALK-8, a novel type I serine/threonine kinase receptor, is expressed throughout early zebrafish development.
Yelick PC; Abduljabbar TS; Stashenko P
Dev Dyn; 1998 Apr; 211(4):352-61. PubMed ID: 9566954
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of rat transforming growth factor-beta type II receptor.
Tsuchida K; Lewis KA; Mathews LS; Vale WW
Biochem Biophys Res Commun; 1993 Mar; 191(3):790-5. PubMed ID: 8385453
[TBL] [Abstract][Full Text] [Related]
6. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.
Lewis KA; Gray PC; Blount AL; MacConell LA; Wiater E; Bilezikjian LM; Vale W
Nature; 2000 Mar; 404(6776):411-4. PubMed ID: 10746731
[TBL] [Abstract][Full Text] [Related]
7. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI.
Onichtchouk D; Chen YG; Dosch R; Gawantka V; Delius H; Massagué J; Niehrs C
Nature; 1999 Sep; 401(6752):480-5. PubMed ID: 10519551
[TBL] [Abstract][Full Text] [Related]
8. A mouse TGF-beta type I receptor that requires type II receptor for ligand binding.
Suzuki A; Shioda N; Maeda T; Tada M; Ueno N
Biochem Biophys Res Commun; 1994 Feb; 198(3):1063-9. PubMed ID: 8117262
[TBL] [Abstract][Full Text] [Related]
9. The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP.
Kim IY; Zelner DJ; Lee C
Exp Cell Res; 1998 May; 241(1):151-60. PubMed ID: 9633523
[TBL] [Abstract][Full Text] [Related]
10. Identification and developmental expression of two activin receptors in baboon lung.
Zhao Y; Silbajoris R; Young SL
Biochem Biophys Res Commun; 1996 Dec; 229(1):50-7. PubMed ID: 8954082
[TBL] [Abstract][Full Text] [Related]
11. Vascular smooth muscle cells express multiple type I receptors for TGF-beta, activin, and bone morphogenetic proteins.
Agrotis A; Samuel M; Prapas G; Bobik A
Biochem Biophys Res Commun; 1996 Feb; 219(2):613-8. PubMed ID: 8605036
[TBL] [Abstract][Full Text] [Related]
12. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity.
ten Dijke P; Ichijo H; Franzén P; Schulz P; Saras J; Toyoshima H; Heldin CH; Miyazono K
Oncogene; 1993 Oct; 8(10):2879-87. PubMed ID: 8397373
[TBL] [Abstract][Full Text] [Related]
13. A WD-domain protein that is associated with and phosphorylated by the type II TGF-beta receptor.
Chen RH; Miettinen PJ; Maruoka EM; Choy L; Derynck R
Nature; 1995 Oct; 377(6549):548-52. PubMed ID: 7566156
[TBL] [Abstract][Full Text] [Related]
14. Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase.
Greenwald J; Fischer WH; Vale WW; Choe S
Nat Struct Biol; 1999 Jan; 6(1):18-22. PubMed ID: 9886286
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning, genetic mapping, and developmental expression of a bovine transforming growth factor beta (TGF-beta) type I receptor.
Roelen BA; Van Eijk MJ; Van Rooijen MA; Bevers MM; Larson JH; Lewin HA; Mummery CL
Mol Reprod Dev; 1998 Jan; 49(1):1-9. PubMed ID: 9406190
[TBL] [Abstract][Full Text] [Related]
17. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
Horie K; Yamashita H; Mogi A; Takenoshita S; Miyazono K
J Cell Physiol; 1998 Jun; 175(3):305-13. PubMed ID: 9572475
[TBL] [Abstract][Full Text] [Related]
18. Expression of TGF-beta superfamily receptors in dental pulp.
Toyono T; Nakashima M; Kuhara S; Akamine A
J Dent Res; 1997 Sep; 76(9):1555-60. PubMed ID: 9294489
[TBL] [Abstract][Full Text] [Related]
19. Induction of transforming growth factor beta 1 and its receptor expression during myeloid leukemia cell differentiation.
Taipale J; Matikainen S; Hurme M; Keski-Oja J
Cell Growth Differ; 1994 Dec; 5(12):1309-19. PubMed ID: 7696179
[TBL] [Abstract][Full Text] [Related]
20. GH3 pituitary tumor cells contain heteromeric type I and type II receptor complexes for transforming growth factor beta and activin-A.
Moustakas A; Takumi T; Lin HY; Lodish HF
J Biol Chem; 1995 Jan; 270(2):765-9. PubMed ID: 7822308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
